Loblaw boosts profit on generic GLP-1 drug sales, bargain hunting shoppers

Loblaw, Canada's largest grocer, has found a new revenue stream by selling generic GLP-1 drugs, which has boosted its profits significantly. Sales of these medications have surged by 40% year-to-date, showing the company's strategic pivot towards healthier offerings is paying off. This move highlights the growing trend of grocery stores expanding beyond traditional products to include pharmaceuticals, reflecting a broader shift in consumer health priorities. The success of this venture could set a precedent for other retailers to follow suit and diversify their product lines.